Topokine Therapeutics, Inc.
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
4
Ending by 2030
Mar 2027
Next term end
When these terms end
Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Nov 26, 2026The maintenance fee for Compositions for Topical Delivery of Prostaglandins to Subcutaneous Fat (US 9,040,584) comes due Nov 26, 2026. Unpaid by May 26, 2027, it lapses early.
- 2 fees due Jan 2 to 28, 2027 · next Jan 2
- 1 fee due May 10, 2027The maintenance fee for Tafluprost and analogs thereof for reducing fat (US 9,180,130) comes due May 10, 2027. Unpaid by Nov 10, 2027, it lapses early.
- 1 fee due Jul 26, 2027The maintenance fee for Lactol and acetal intermediates for making prostaglandins (US 9,242,954) comes due Jul 26, 2027. Unpaid by Jan 26, 2028, it lapses early.
- 1 fee due Aug 11, 2027The maintenance fee for Compositions and Methods for Topical Delivery of Prostaglandins to Subcutaneous Fat (US 10,556,012) comes due Aug 11, 2027. Unpaid by Feb 11, 2028, it lapses early.
Recent changes
- 1 term has ended since Aug 23, 2026
- Sep 9 US 8,829,050 Compositions and Methods for Reducing Body Fat · lapsed on the fee record
Patents held now
Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 7,666,912 | Compositions and Methods for Reducing Body Fat In force · High confidence | In force | High confidence | |
| US 9,144,574 | Compositions and Methods for Reducing Body Fat In force · High confidence | In force | High confidence | |
| US 9,421,215 | Compositions and Methods for Reducing Body Fat In force · Medium confidence | In force | Medium confidence | |
| US 10,285,995 | Compositions and Methods for Reducing Body Fat In force · Medium confidence | In force | Medium confidence | |
| US 9,504,695 | Methods for reducing body fat In force · USPTO record | In force | USPTO record | |
| US 10,335,418 | Methods and compositions for treating metabolic syndrome In force · USPTO record | In force | USPTO record | |
| US 9,089,579 | Methods and compositions for treating metabolic syndrome In force · USPTO record | In force | USPTO record | |
| US 9,180,130 | Tafluprost and analogs thereof for reducing fat In force · USPTO record | In force | USPTO record | |
| US 9,242,954 | Lactol and acetal intermediates for making prostaglandins In force · USPTO record | In force | USPTO record | |
| US 9,040,584 | Compositions for Topical Delivery of Prostaglandins to Subcutaneous Fat In force · Medium confidence | In force | Medium confidence |
Also on record, not counted in the 13: 9 lapsed for an unpaid fee · 1 past the fee grace period. List them
Sources and methods
Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand.
How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
Published applications
US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.
4 abandoned · 8 no status recorded